trending Market Intelligence /marketintelligence/en/news-insights/trending/ia8jynbyfsyvrvt1ylnhpa2 content esgSubNav
In This List

CVS CFO to leave after close of Aetna acquisition

Blog

Using ESG Analysis to Support a Sustainable Future

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings


CVS CFO to leave after close of Aetna acquisition

CVS Health Corp. announced June 6 that CFO David Denton will leave the pharmacy healthcare services provider after it completes its $69 billion acquisition of health insurer Aetna Inc., which is expected in the second half of 2018, subject to regulatory approval.

Denton, who joined CVS in 1999 and has held various managerial roles, will be succeeded as CFO by Shawn Guertin, Aetna's CFO, executive vice president and chief enterprise risk officer. Guertin also will be named executive vice president of the drug retailer.

Aetna President Karen Lynch will remain in her role after the deal closes, but she also will become a CVS executive vice president.

Aetna Chairman and CEO Mark Bertolini will join the CVS board on the deal's completion as previously disclosed.